Target intelligence / Profile preview

Entry Inhibitor

Molecular classification
Antiviral drug class
01

Overview

Entry inhibitors are a class of antiviral drugs that prevent viruses, most notably HIV, from entering host cells. They achieve this by interfering with the binding, fusion, or entry processes required for viral infection. By blocking these early steps in the viral life cycle, entry inhibitors help slow disease progression and are especially valuable in combination antiretroviral therapy. They target various stages of the virus-cell entry process, including pre-attachment, post-attachment, co-receptor binding, and membrane fusion.

02

Mechanism of action

Blocks virus attachment/fusion/entry into host cell

03

Biological functions

Inhibition of viral entryAntiviral activity
04

Disease associations

HIV infectionViral infections
05

Safety considerations

Resistance developmentTropism switchingSide effects specific to individual drugs within the class
06

Interacting drugs

Fostemsavir

4 more in the full profile.

Beyond the preview

Go deeper on Entry Inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Entry Inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call